Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200427210> ?p ?o ?g. }
- W4200427210 endingPage "6367" @default.
- W4200427210 startingPage "6367" @default.
- W4200427210 abstract "The aim of our study was to assess if the sodium salt of cobaltabis(dicarbollide) and its di-iodinated derivative (Na[o-COSAN] and Na[8,8'-I2-o-COSAN]) could be promising agents for dual anti-cancer treatment (chemotherapy + BNCT) for GBM.The biological activities of the small molecules were evaluated in vitro with glioblastoma cells lines U87 and T98G in 2D and 3D cell models and in vivo in the small model animal Caenorhabditis elegans (C. elegans) at the L4-stage and using the eggs.Our studies indicated that only spheroids from the U87 cell line have impaired growth after treatment with both compounds, suggesting an increased resistance from T98G spheroids, contrary to what was observed in the monolayer culture, which highlights the need to employ 3D models for future GBM studies. In vitro tests in U87 and T98G cells conclude that the amount of 10B inside the cells is enough for BNCT irradiation. BNCT becomes more effective on T98G after their incubation with Na[8,8'-I2-o-COSAN], whereas no apparent cell-killing effect was observed for untreated cells.These small molecules, particularly [8,8'-I2-o-COSAN]-, are serious candidates for BNCT now that the facilities of accelerator-based neutron sources are more accessible, providing an alternative treatment for resistant glioblastoma." @default.
- W4200427210 created "2021-12-31" @default.
- W4200427210 creator A5013712213 @default.
- W4200427210 creator A5018433958 @default.
- W4200427210 creator A5023802822 @default.
- W4200427210 creator A5039463526 @default.
- W4200427210 creator A5056419519 @default.
- W4200427210 creator A5058346914 @default.
- W4200427210 creator A5063181652 @default.
- W4200427210 creator A5071216517 @default.
- W4200427210 creator A5080913090 @default.
- W4200427210 creator A5084168197 @default.
- W4200427210 creator A5084236161 @default.
- W4200427210 creator A5091447570 @default.
- W4200427210 date "2021-12-19" @default.
- W4200427210 modified "2023-10-06" @default.
- W4200427210 title "Cobaltabis(dicarbollide) ([o-COSAN]−) as Multifunctional Chemotherapeutics: A Prospective Application in Boron Neutron Capture Therapy (BNCT) for Glioblastoma" @default.
- W4200427210 cites W141434044 @default.
- W4200427210 cites W1483601651 @default.
- W4200427210 cites W1944127002 @default.
- W4200427210 cites W1966916682 @default.
- W4200427210 cites W1968885557 @default.
- W4200427210 cites W1987225974 @default.
- W4200427210 cites W1988189380 @default.
- W4200427210 cites W1991147890 @default.
- W4200427210 cites W1991690485 @default.
- W4200427210 cites W2005203290 @default.
- W4200427210 cites W2006702655 @default.
- W4200427210 cites W2008482870 @default.
- W4200427210 cites W2012693372 @default.
- W4200427210 cites W2018223635 @default.
- W4200427210 cites W2028991191 @default.
- W4200427210 cites W2036291177 @default.
- W4200427210 cites W2038163349 @default.
- W4200427210 cites W2039687515 @default.
- W4200427210 cites W2063378958 @default.
- W4200427210 cites W2072776117 @default.
- W4200427210 cites W2073694296 @default.
- W4200427210 cites W2076187208 @default.
- W4200427210 cites W2080467735 @default.
- W4200427210 cites W2082332887 @default.
- W4200427210 cites W2085864374 @default.
- W4200427210 cites W2087019695 @default.
- W4200427210 cites W2096287682 @default.
- W4200427210 cites W2101732161 @default.
- W4200427210 cites W2103312948 @default.
- W4200427210 cites W2112481330 @default.
- W4200427210 cites W2117783753 @default.
- W4200427210 cites W2119412999 @default.
- W4200427210 cites W2120530423 @default.
- W4200427210 cites W2122998798 @default.
- W4200427210 cites W2125746135 @default.
- W4200427210 cites W2132317577 @default.
- W4200427210 cites W2135014518 @default.
- W4200427210 cites W2135732933 @default.
- W4200427210 cites W2138239793 @default.
- W4200427210 cites W2142633038 @default.
- W4200427210 cites W2148287035 @default.
- W4200427210 cites W2322107771 @default.
- W4200427210 cites W2392045628 @default.
- W4200427210 cites W2406091788 @default.
- W4200427210 cites W2409261295 @default.
- W4200427210 cites W2418203839 @default.
- W4200427210 cites W2563101083 @default.
- W4200427210 cites W2580322958 @default.
- W4200427210 cites W2584293043 @default.
- W4200427210 cites W2626151272 @default.
- W4200427210 cites W2748212730 @default.
- W4200427210 cites W2769184795 @default.
- W4200427210 cites W2771860623 @default.
- W4200427210 cites W2772195672 @default.
- W4200427210 cites W2790352034 @default.
- W4200427210 cites W2808082798 @default.
- W4200427210 cites W2808610925 @default.
- W4200427210 cites W2891488717 @default.
- W4200427210 cites W2909978237 @default.
- W4200427210 cites W2913817565 @default.
- W4200427210 cites W2921440790 @default.
- W4200427210 cites W2968601567 @default.
- W4200427210 cites W3002928757 @default.
- W4200427210 cites W3010020228 @default.
- W4200427210 cites W3020711625 @default.
- W4200427210 cites W3021332631 @default.
- W4200427210 cites W3039130959 @default.
- W4200427210 cites W3078854008 @default.
- W4200427210 cites W3110047728 @default.
- W4200427210 cites W3125304574 @default.
- W4200427210 cites W3153332542 @default.
- W4200427210 cites W315365876 @default.
- W4200427210 cites W3201122963 @default.
- W4200427210 cites W4229550919 @default.
- W4200427210 cites W4235998466 @default.
- W4200427210 cites W883757128 @default.
- W4200427210 doi "https://doi.org/10.3390/cancers13246367" @default.
- W4200427210 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34944987" @default.
- W4200427210 hasPublicationYear "2021" @default.
- W4200427210 type Work @default.
- W4200427210 citedByCount "16" @default.